Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Genfit
(OTCPK:GNFTF)
Intraday
$2.95
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$2.95
0
[0.00%]
At close: Apr 15
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Genfit Stock (OTC:GNFTF)
Genfit Stock (OTC: GNFTF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, October 07, 2019
Stocks That Hit 52-Week Lows Of Monday
Lisa Levin
-
Oct 7, 2019, 11:09AM
Tuesday, October 01, 2019
Stocks That Hit 52-Week Lows On Tuesday
Lisa Levin
-
Oct 1, 2019, 2:35PM
Monday, September 30, 2019
Stocks That Hit 52-Week Lows On Monday
Lisa Levin
-
Sep 30, 2019, 11:20AM
Wednesday, March 27, 2019
Genfit Prices 6.15M ADS IPO @$20.32/ADS
Charles Gross
-
Mar 27, 2019, 4:09AM
Friday, January 18, 2019
Searching For A Treatment: NASH Investigational Drugs With Catalysts This Year
Shanthi Rexaline
-
Jan 18, 2019, 9:15AM
Thursday, March 31, 2016
GENFIT to Begin Elafibranor Clinical Program in PBC
Benzinga
-
Mar 31, 2016, 7:47AM
Wednesday, March 09, 2016
Roth's Piros: Galectin Therapeutics Shares Can Quadruple In Next 12 Months
Benzinga
-
Mar 9, 2016, 3:00PM
Thursday, February 11, 2016
GENFIT @genfit_pharma Tweet: GENFIT - Gastroenterology: Press release tonight after market closes - @AmerGastroAssn #NASH #liverdisease
Benzinga
-
Feb 11, 2016, 5:55AM
Monday, February 17, 2014
Genfit Announces FDA Grants Fast Track Designation to GFT505 in NASH
Benzinga
-
Feb 17, 2014, 11:55AM
